source
- Key data on lipoprotein(a)-targeting cardiovascular drugs expected soonA STAT+ newsletter highlights that several major pharmaceutical firms are developing drugs that lower lipoprotein(a), a particle linked to heart disease. The companies view Lp(a) reduction as a po…
- Insitro CEO Daphne Koller discusses using AI to accelerate clinical trialsSTAT+ AI Prognosis newsletter featured an interview with Insitro chief executive Daphne Koller about the role of artificial intelligence in drug discovery and how it could speed up clinical trials.…